Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
about
Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer AgentsIncreased reactive oxygen species production during reductive stress: The roles of mitochondrial glutathione and thioredoxin reductases.Selenium and selenocysteine: roles in cancer, health, and development.New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 statusWhich form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease.Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.Diverse Molecular Targets for Chalcones with Varied Bioactivities.Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State.Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents.Chalcone: A Privileged Structure in Medicinal Chemistry.Targeting oxidative stress in embryonal rhabdomyosarcoma.Auranofin, a thioredoxin reductase inhibitor, causes platelet death through calcium overload.Spatio-temporal changes in glutathione and thioredoxin redox couples during ionizing radiation-induced oxidative stress regulate tumor radio-resistance.Evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine as an irreversible inhibitor of mammalian thioredoxin reductase1.Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells.
P2860
Q26800031-1C60459D-DA11-4BB0-B87E-8E2D764B5A75Q35588949-0E34C5B1-D7A3-4A4F-ACFD-BA12E87D8126Q37619604-D31EF507-4098-4BB1-A6CE-9CDEDA1812DCQ37686897-4E9743C7-C5E0-420A-8838-ECEA81F8488EQ38137010-43C5BA2C-A893-4B09-8338-83A6DEF2790FQ38637192-796DDBA3-7124-49E4-AE6E-AA62431E7511Q38707609-F22D60DC-7306-496F-8167-395DB4851D75Q38786513-AD13B708-BA8D-425F-9081-012DC539B082Q38850175-6C7623B4-E515-40E0-A2F2-9CA60D67FA76Q39295083-A4533052-5FB2-4A5C-94C7-CCBBA221F2D3Q41896211-41D8A87C-6F5D-4CE7-8225-A9912425FA4DQ46250307-9E0BF545-F1AB-4241-B5EE-9167E8B85557Q46722577-8DD59138-8BCD-47AE-890F-CE323E872D1FQ53576033-88197777-23E2-46A5-9067-A76C9DF2972BQ53745075-07C6184E-1A73-4823-A451-05ECDD877F6A
P2860
Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recent advances in the develop ...... hibitors as anticancer agents.
@en
type
label
Recent advances in the develop ...... hibitors as anticancer agents.
@en
prefLabel
Recent advances in the develop ...... hibitors as anticancer agents.
@en
P2093
P1433
P1476
Recent advances in the develop ...... hibitors as anticancer agents.
@en
P2093
Guisen Zhao
Shenghui Yu
P304
P356
10.2174/138945012803530224
P577
2012-10-01T00:00:00Z